Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BECL backing off on non-510(k) cleared clients. (Medical devices).


A Feb. 25-March 5 inspection of Biological and Environmental Control Laboratories (BECL BECL Balfours Environmental Consultants Ltd (UK) ) by FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 uncovered cleaning and sterilization sterilization

Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system).
 validation deficiencies for the firm's reprocessed, single-use limb compression sleeve devices.

However, it was not until a June 20 warning letter (Doc. 11794W) that the agency stated the Toledo, OH-based firm was marketing the reprocessed devices without a cleared 510(k).

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 documents released by the agency, BECL reprocessed single-use compressible com·press·i·ble  
adj.
That can be compressed: compressible packing materials; a compressible box.



com·press
 limb sleeves from two firms. One was Millennium Reprocessing Reprocessing may refer to:
  • Nuclear reprocessing
  • Recycling
 Services, Inc., which received June 14 510(k) clearance for the devices to be reprocessed, FDA stated.

The other limb sleeve firm only was identified as "MDR MDR,
n See multidrug resistance.

MDR,
n the abbreviation for minimum daily requirement, specifically the Minimum Daily Requirements for Specific Nutrients compiled by the United States Food and Drug Administration.
," but it did not have a 510(k), according to FDA. BECL Quality Assurance Manager John Blair

For other people named John Blair, see John Blair (disambiguation).
John Blair (1732–August 31, 1800) was an American politician, Founding Father, and Patriot.

John Blair was one of the best-trained jurists of his day.
 stated in a July 8 letter to the agency that the firm would discontinue working with companies that do not have 510(k) clearance for their products.

Until the firm in question received a 510(k), BECL would not "participate in any reprocessing activities associated with this firm," the exec told the agency.

Investigator Phillip Pontikos of the Cincinnati District noted in his three-page 483 that the validation protocol for ethylene oxide ethylene oxide Occupational medicine A gas used to sterilize medical supplies and other materials  (EO) sterilization dated Aug. 31, 2001, had not been signed as completed, adding that the validation had not been fully completed and documented.

Cincinnati District Director Henry Fielden continued in the warning letter that BECL's sterilization process had "not been fully completed and documented" nor were bioburden studies performed or specific load configurations during sterilization cycles established or defined.

Pontikos continued that specific load configurations had not been established or defined, that there was no documentation showing that testing was conducted for pyrogenicity of for determining the bioburden levels for all types of reprocessed medical devices. He added that BECL did not have documentation showing that packaging materials and operations "provide a microbial microbial

pertaining to or emanating from a microbe.


microbial digestion
the breakdown of organic material, especially feedstuffs, by microbial organisms.
 barrier and maintains package closure and seal integrity after sterilization, handling, shipping, and storage."

Blair noted the firm would address the issues of EO sterilization when the unnamed firm in question obtained 510(k) clearance.

Pontikos also cited BECL for not having documentation to demonstrate that cleaning process for each type of compression garment had been validated, records stated.

Specifically, Pontikos cited a lack of documentation defining specifications prior to conduction conduction, transfer of heat or electricity through a substance, resulting from a difference in temperature between different parts of the substance, in the case of heat, or from a difference in electric potential, in the case of electricity.  testing. Also, the inspector noted that subjective assessments were used to determine cleanliness and dryness of devices.

Blair defended the cleaning process, stating this was validated and attached a copy of the protocol with his response. In a cleaning evaluation using the protocol, Blair noted "a percent reduction in bacterial counts of 99.36%."

Noting management had not ensured that the quality system was fully implemented and maintained, Pontikos also noted lack of a written quality plan for the reprocessing of single-use devices, no review of reprocessing medical devices in management review meetings, and that quality audits were not being done "with sufficient frequency to detect quality system defects."

Blair responded that BECL's reprocessing of sleeves began in 1999 before the company's ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9001 certification in December 2000 and that this was the reason a quality plan was not available for these devices. According to the letter, the firm attached a copy of the quality plan in the response.

Concerning management reviews, Blair again noted the predating of sleeve reprocessing to ISO 9001 certification and responded that management review meetings occurred every six months and that there would be "a section dedicated to the reprocessing of compressible sleeves" in July 2002.

FDA stated the FIR was not being released as it "could reasonably be expected to interfere with enforcement proceedings." Calls into BECL requesting comment were not returned as of deadline.

Biological and Environmental Control Laboratories, Toledo, OH, 2/25, 27-28, 3/1, 4, 5/02, Doc. 109316M, $5.50 plus retrieval.

[check] The Checklist--BECL

[check] cleaning and sterilization validation

[check] validation protocol incomplete/ undocumented

[check] documentation specifications

[check] quality system
COPYRIGHT 2002 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Validation Times
Date:Nov 1, 2002
Words:650
Previous Article:Uncertified anti-fungus oil, labeling sends OTC firm to clean up act. (Human drugs).
Next Article:Red Cross validation and QA/QC leaves much to be desired, FDA said. (Blood & Biologics).



Related Articles
Pouncing on off-label Oratec Internet promo, FDA slaps references to news media.
CDRH UNTITLED LETTERS.
CDRH promo untitled letters.
CDRH promo untitled letters.
Reprocessor stops taking non-510(k)-cleared clients. (Medical Devices).
Device reprocessor lacks cleaning/sterility validation, 510(k), FDA says.
CDRH promo untitled letters.
CDRH promo untitled letters.
Medical devices.
CDRH promo untitled letters.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles